Russia’s Tyumen keen on hosting Indian pharma ventures

Reaches out to Indian officials, Pharmexcil; offers municipal land, tax sops, investment loans to attract foreign investments

June 24, 2018 12:30 am | Updated 12:30 am IST - HYDERABAD

Tyumen has joined a growing list of Russian regions keen on playing host to pharmaceutical ventures of Indian firms, a move that comes in the backdrop of Russia’s emphasis on building self reliance in drug production.

A front-ranking official of Tyumen Government met with Indian officials in Moscow last month, on the sidelines of the India-Russia Working Group on trade and economic cooperation, and conveyed the region’s interest. Simultaneously, the government of Tyumen also reached out to Pharmexcil, seeking the export promotion council’s assistance in spreading the word. Tyumen follows Tatarstan, which had in March despatched an official delegation to promote investment opportunities in its region for India pharma manufacturers. Some of the benefits Tyumen offers to attract foreign investment include, provision of municipal land, tax sops, including those pertaining to income and property, besides investment loans. Pharmexcil Director General Ravi Uday Bhaskar had circulated a communication in this regard to the members.

Almost a year ago, Chelyabinsk region had sought proposals from Indian pharmaceutical companies looking to set up manufacturing units in its region with a local partner. Uzbekistan, among CIS countries, is keen on giving a push to the growth of the pharmaceutical industry by attracting FDIs.

New regulation on cards

The efforts of the regions to attract Indian pharma companies assume significance as Russia, from 2019, would implement a new regulation giving preference of 25% in State medicine procurement tenders for products produced in a full cycle in the Eurasian Economic Union. By definition, it would give an edge to such products (full cycle related to production of APIs to formulation of the product).

One of the important markets for Indian firms, Russia, however, has put in place a few other mechanisms to encourage domestic manufacturing. Pharmaceutical exports to Russia grew a shade over 22% in 2017-18 to $468 million ($383 million).

According to the Pharmaceuticals Export Promotion Council of India, Russia figures in the list of four countries to which exports grew above 20% in 2017-18. China, South Africa and Italy are others in the list and together the four countries contributed about 9% to the country’s pharma exports.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.